Home About us Editorial board Ahead of print Current issue Archives Submit article Instructions Subscribe Search Contacts Login 
  • Users Online: 848
  • Home
  • Print this page
  • Email this page
Year : 2011  |  Volume : 23  |  Issue : 5  |  Page : 340-343

Oxcarbazepine: Drug of the future in the treatment of trigeminal neuralgia

1 Reader, Department of Oral Medicine and Radiology, Modern Dental College, Indore, Madhya Pradesh, India
2 Professor and Head, Department of Oral Medicine and Radiology, King George Medical College, Lucknow, Uttar Pradesh, India
3 Department of Public Health Dentistry, People's College of Dental Sciences and Research Centre, Bhopal, Madhya Pradesh, India
4 Senior Lecturer, Department of Oral Medicine and Radiology, MGVs KBH Dental College and Hospital, Nashik, Maharashtra, India
5 Senior Lecturer, Department of Oral Pathology and Microbiology, SP Dental College, Wardha, Maharashtra, India

Correspondence Address:
Revant H Chole
Reader, Department of Oral Medicine and Radiology, Modern Dental College Indore-453112, Madhya Pradesh
Login to access the Email id

Source of Support: None, Conflict of Interest: None

DOI: 10.5005/jp-journals-10011-1164

Rights and Permissions

Background: The aim of the study was to estimate the efficacy of oxcarbazepine in trigeminal neuralgia. Oxcarbazepine is a novel antiepilepfic drug, and its effect on trigeminal neuralgia has not been studied extensively previously. Materials and methods: Fifty-three patients with trigeminal neuralgia (34 men and 19 women) took a mean dose of 600 mg of oxcarbazepine for a period of three weeks. Pain intensity was measured by using visual analog scale. Results: Of the 53 patients, 42 (79%) were completely or well controlled by OXC, and nine (17%) partially but acceptably controlled. Treatment with OXC was therefore satisfactory initially in 51 (96%) of the patients. In seven of these patients, mild transient side effects occurred but did not necessitate cessation of treatment Conclusion: OXC appears to be an effective substitute for carbamazepine in those patients intolerant of this agent, or experiencing significant side effects.

Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)

 Article Access Statistics
    PDF Downloaded77    
    Comments [Add]    

Recommend this journal